Mayflower Financial Advisors LLC Reduces Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Mayflower Financial Advisors LLC lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 19.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,663 shares of the pharmacy operator’s stock after selling 1,354 shares during the period. Mayflower Financial Advisors LLC’s holdings in Walgreens Boots Alliance were worth $212,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Sage Private Wealth Group LLC purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at approximately $25,000. EverSource Wealth Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 289.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 915 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 680 shares during the period. Bank of New Hampshire grew its stake in shares of Walgreens Boots Alliance by 56.4% in the 3rd quarter. Bank of New Hampshire now owns 960 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 346 shares during the period. Blume Capital Management Inc. grew its stake in shares of Walgreens Boots Alliance by 35.7% in the 3rd quarter. Blume Capital Management Inc. now owns 950 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 250 shares during the period. Finally, Lindbrook Capital LLC grew its stake in shares of Walgreens Boots Alliance by 826.3% in the 4th quarter. Lindbrook Capital LLC now owns 880 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 785 shares during the period. Hedge funds and other institutional investors own 56.71% of the company’s stock.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CEO Rosalind G. Brewer acquired 10,000 shares of the stock in a transaction dated Wednesday, March 29th. The shares were bought at an average price of $33.95 per share, with a total value of $339,500.00. Following the purchase, the chief executive officer now directly owns 369,945 shares of the company’s stock, valued at approximately $12,559,632.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 17.50% of the company’s stock.

Analysts Set New Price Targets

WBA has been the topic of a number of research reports. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a report on Thursday, March 16th. They set a “hold” rating on the stock. Loop Capital began coverage on shares of Walgreens Boots Alliance in a report on Wednesday, February 22nd. They issued a “buy” rating and a $45.00 price objective on the stock. Mizuho restated a “neutral” rating and issued a $41.00 price objective on shares of Walgreens Boots Alliance in a report on Wednesday, March 29th. Morgan Stanley reduced their price objective on shares of Walgreens Boots Alliance from $39.00 to $37.00 and set an “underweight” rating on the stock in a report on Monday, January 30th. Finally, Credit Suisse Group dropped their target price on shares of Walgreens Boots Alliance from $42.00 to $41.00 and set a “neutral” rating on the stock in a research report on Friday, January 6th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $42.46.

Walgreens Boots Alliance Trading Down 0.9 %

NASDAQ WBA opened at $35.78 on Friday. Walgreens Boots Alliance, Inc. has a 12 month low of $30.39 and a 12 month high of $47.28. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.63 and a quick ratio of 0.32. The company has a market capitalization of $30.87 billion, a price-to-earnings ratio of -9.80, a price-to-earnings-growth ratio of 2.63 and a beta of 0.71. The company’s fifty day moving average price is $35.23 and its two-hundred day moving average price is $36.34.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last posted its quarterly earnings results on Tuesday, March 28th. The pharmacy operator reported $1.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.06. Walgreens Boots Alliance had a negative net margin of 2.36% and a positive return on equity of 12.42%. The company had revenue of $34.86 billion for the quarter, compared to the consensus estimate of $33.56 billion. During the same period last year, the firm posted $1.59 EPS. The company’s revenue for the quarter was up 3.3% on a year-over-year basis. As a group, research analysts predict that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 10th. Stockholders of record on Thursday, February 16th were paid a $0.48 dividend. The ex-dividend date was Wednesday, February 15th. This represents a $1.92 annualized dividend and a dividend yield of 5.37%. Walgreens Boots Alliance’s dividend payout ratio is currently -52.60%.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.

Read More

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.